INGN
Inogen, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.42
−0.55%0
Insider buys (3m)
1
Insider sells (3m)
-$72.1K
Net value (3m)
-15.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Wright Mary E · officer: VP, Chief Accounting Officer | A-Award | 1,500 | $5.33 |
| Sep 3, 2026 | Smith Kevin P. · officer: EVP, Bus Dev, GC & Sec | M-Exempt | 18,136 | $0.00 |
| Sep 3, 2026 | Smith Kevin P. · officer: EVP, Bus Dev, GC & Sec | F-InKind | 8,671 | $5.33 |
| Sep 3, 2026 | Smith Kevin P. · officer: EVP, Bus Dev, GC & Sec | A-Award | 1,500 | $5.33 |
| Sep 3, 2026 | Smith Kevin Raymond Merrill · director, officer: CEO and President | A-Award | 1,500 | $5.33 |
| Jul 9, 2026 | Reding Andrew P. · officer: EVP, COO | A-Award | 130,000 | $0.00 |
| Jul 6, 2026 | Yi Boyer Jennifer M · officer: EVP Entrprs Enblmnt, Ch HR Off | Sale | 10,938 | $6.60 |
| Jun 9, 2026 | Sahney Mira Kirti · director | A-Award | 28,081 | $0.00 |
| Jun 9, 2026 | Ladone Mary Kay · director | A-Award | 28,081 | $0.00 |
| Jun 9, 2026 | King Kevin M · director | A-Award | 28,081 | $0.00 |
| Jun 9, 2026 | Jamali Vafa · director | A-Award | 28,081 | $0.00 |
| Jun 9, 2026 | Mora Elizabeth · director | A-Award | 28,081 | $0.00 |
| Jun 9, 2026 | Rider Heather D. · director | A-Award | 28,081 | $0.00 |
| Jun 9, 2026 | Boehnlein Glenn S · director | A-Award | 28,081 | $0.00 |
| Jun 2, 2026 | Yi Boyer Jennifer M · officer: EVP Entrprs Enblmnt, Ch HR Off | Sale | 10,770 | $6.53 |
| Apr 8, 2026 | Richardson Jason Andrew · officer: EVP, CFO & Treasurer | A-Award | 100,000 | $0.00 |
| Dec 2, 2025 | Smith Kevin Raymond Merrill · director, officer: CEO and President | M-Exempt | 28,334 | $0.00 |
| Dec 2, 2025 | Ramade Gregoire · officer: Chief Commercial Officer | M-Exempt | 31,566 | $0.00 |
| Dec 2, 2025 | Smith Kevin Raymond Merrill · director, officer: CEO and President | F-InKind | 13,817 | $6.95 |
| Dec 2, 2025 | Ramade Gregoire · officer: Chief Commercial Officer | F-InKind | 12,943 | $6.95 |
| Sep 3, 2025 | Smith Kevin P. · officer: EVP, Bus Dev, GC & Sec | A-Award | 1,500 | $7.99 |
| Sep 3, 2025 | Bourque Michael J. · officer: EVP, CFO & Treasurer | A-Award | 1,500 | $7.99 |
| Sep 3, 2025 | Smith Kevin P. · officer: EVP, Bus Dev, GC & Sec | F-InKind | 8,043 | $7.99 |
| Sep 3, 2025 | Smith Kevin P. · officer: EVP, Bus Dev, GC & Sec | M-Exempt | 18,135 | $0.00 |
| Sep 3, 2025 | Smith Kevin Raymond Merrill · director, officer: CEO and President | A-Award | 1,500 | $7.99 |
| May 19, 2025 | Boehnlein Glenn S · director | A-Award | 30,612 | $0.00 |
| May 16, 2025 | King Kevin M · director | A-Award | 30,612 | $0.00 |
| May 16, 2025 | Ladone Mary Kay · director | A-Award | 30,612 | $0.00 |
| May 16, 2025 | Sahney Mira Kirti · director | A-Award | 30,612 | $0.00 |
| May 16, 2025 | Mora Elizabeth · director | A-Award | 30,612 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 42Increased 109Reduced 74Sold out 14
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 1,748,986 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 1,647,084 | May 13, 2026 |
| ARMISTICE CAPITAL, LLC | Reduced | 1,200,000 | May 15, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 1,096,879 | Aug 13, 2026 |
| ARMISTICE CAPITAL, LLC | Reduced | 1,096,000 | Aug 14, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Unchanged | 1,083,483 | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 1,038,316 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,036,705 | May 15, 2026 |
| AMERIPRISE FINANCIAL INC | Increased | 983,028 | Aug 14, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Increased | 937,334 | Aug 14, 2026 |
| AMERIPRISE FINANCIAL INC | Reduced | 859,543 | Jul 17, 2026 |
| DAFNA Capital Management LLC | Unchanged | 845,179 | Aug 14, 2026 |
| DAFNA CAPITAL MANAGEMENT LLC | Increased | 845,179 | May 15, 2026 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | Increased | 743,252 | Aug 13, 2026 |
| MORGAN STANLEY | Increased | 646,276 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026